ELUCIDATE: Enabling Lung Cancer Identification Using Folate Receptor Targeting

NCT04241315 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
112
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

On Target Laboratories, LLC

Collaborators